Русский
Insulin Pump Therapy - A Way To Achieve Clinical And Metabolic Compensation Of The Disease In Children And Adolescents With Type 1 Diabetes Mellitus
E.E. Petryaikina, O.V. Duchareva, I.G. Ryibkina, E.A. Pronina, T.D. Michailova, I.V. Garyaeva, E.T. Mandjieva
Insulin pump therapy - a way to achieve clinical and metabolic compensation of the disease in children and adolescents with type 1 diabetes mellitus
We consider the advantages and disadvantages of intensified insulin therapy in children and adolescents with type 1 diabetes mellitus (type 1 diabetes), in terms of opportunities to achieve and maintain compensation for this disease. The expediency of translation of this population of patients with type 1 diabetes for insulin pump therapy (IPT) is discussed. The results of evaluating the effectiveness of prolonged IPT use in 105 children and adolescents with type 1 diabetes with poor disease control before the application of this method of treatment are presented. It has been established that the IPT is effective way to improvement of clinical and metabolic compensation of type 1 diabetes in children and adolescents with poor disease control. Its appointment enhances the indices of glycemic control, allows reducing the average daily dose of insulin, prevents the development of severe hypoglycemia and episodes of diabetic ketoacidosis requiring hospitalization, and increases the quality of life of patients.
We consider the advantages and disadvantages of intensified insulin therapy in children and adolescents with type 1 diabetes mellitus (type 1 diabetes), in terms of opportunities to achieve and maintain compensation for this disease. The expediency of translation of this population of patients with type 1 diabetes for insulin pump therapy (IPT) is discussed. The results of evaluating the effectiveness of prolonged IPT use in 105 children and adolescents with type 1 diabetes with poor disease control before the application of this method of treatment are presented. It has been established that the IPT is effective way to improvement of clinical and metabolic compensation of type 1 diabetes in children and adolescents with poor disease control. Its appointment enhances the indices of glycemic control, allows reducing the average daily dose of insulin, prevents the development of severe hypoglycemia and episodes of diabetic ketoacidosis requiring hospitalization, and increases the quality of life of patients.
